CSIMarket
 


Frequency Therapeutics Inc   (FREQ)
Other Ticker:  
 

Cumulative Frequency Therapeutics Inc 's Total Debt to Equity for Trailing Twelve Months Period

FREQ's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

FREQ Total Debt to Equity for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -44.28 % -42.27 % -36.49 % -32.04 % -26.29 %
Y / Y Total Debt Growth 0 % 0 % 0 % 0 % -
Total Debt to Equity for Trailing Twelve Months Period 0.14 0.12 0.11 0.1 0.09
Total Ranking # 1067 # 910 # 494 # 167 #
Seq. Equity Growth -14.48 % -14.93 % -13.88 % -11.07 % -11.4 %
Seq. Total Debt Growth 0 % 0 % 0 % 0 % 0 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite repayements of liabilities of 0% in III. Quarter, Total Debt to Equity for Trailing Twelve Months Period improved to 0.14, above Frequency Therapeutics Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 73 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Frequency Therapeutics Inc . While Total Debt to Equity for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 910 to 1067.

What is Debt to Equity Ratio?
FREQ Charts and Quotes
Total Debt to Equity FREQ in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 74
Sector # 210
S&P 500 # 1066


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.04 0.02 0
(Sep 30 2022)   (Dec 31 2021)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Journey Medical Corporation  0.39 
Neptune Wellness Solutions Inc   0.38 
Seres Therapeutics Inc   0.38 
Biodelivery Sciences International Inc   0.38 
Cytokinetics Incorporated  0.37 
Otonomy Inc   0.37 
4d Pharma Plc  0.37 
Seelos Therapeutics Inc   0.36 
Geron Corp  0.35 
Medavail Holdings Inc   0.34 
Corbus Pharmaceuticals Holdings Inc   0.32 
Organogenesis Holdings Inc   0.32 
Scpharmaceuticals Inc   0.31 
Arcutis Biotherapeutics Inc   0.30 
Sigilon Therapeutics Inc   0.30 
Bioxcel Therapeutics Inc   0.30 
Tg Therapeutics inc   0.29 
Vaxxinity Inc   0.28 
Arcturus Therapeutics Holdings Inc   0.28 
Metacrine Inc   0.27 
Gossamer Bio Inc   0.27 
Vbi Vaccines Inc  0.27 
Alkermes Plc   0.27 
Amryt Pharma Plc  0.26 
Trevi Therapeutics Inc   0.26 
Novan Inc   0.26 
Legend Biotech Corporation  0.26 
Ligand Pharmaceuticals Incorporated  0.25 
Kamada Ltd  0.25 
Orgenesis Inc   0.25 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LZB's Profile

Stock Price

LZB's Financials

Business Description

Fundamentals

Charts & Quotes

LZB's News

Suppliers

LZB's Competitors

Customers & Markets

Economic Indicators

LZB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071